| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8995730 | Medical Hypotheses | 2005 | 4 Pages |
Abstract
Thus, early treatment seems necessary in infants with haemangioma, before the endothelial cells achieve their proliferative stage. The use of an antibody to interfere with VEGF receptors provides a particular attractive strategy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Abderrahmane Hamlat, Mahmoudreza Adn, Edouardo Pasqualini, Gilles Brassier, Brahim Askar,